View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
November 17, 2020

Medtronic acquires French spinal implant maker Medicrea

Medtronic has completed its friendly tender offer to acquire France-based artificial intelligence (AI)-enabled spinal implant manufacturer Medicrea International.

Medtronic has completed its friendly tender offer to acquire France-based artificial intelligence (AI)-enabled spinal implant manufacturer Medicrea International.

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

In July, the companies signed an agreement for the acquisition of all outstanding shares of Medicrea in a voluntary all-cash tender offer priced at €7 ($7.97) per share.

With the completion of the tender offer, Medtronic now owns over 90% of Medicrea’s share capital and voting rights.

The company will also seek the implementation of a squeeze-out procedure under French law, which would make Medicrea a wholly owned subsidiary of Medtronic.

The latest acquisition has become the seventh by Medtronic to be completed this year.

The deal expands Medtronic’s AI and data capabilities and makes it the first company to offer an integrated spine solution, which includes AI-driven surgical planning, personalised spinal implants, and robotic-assisted surgery.

Medtronic Cranial & Spinal Technologies operating unit president Jacob Paul said: “By offering clinicians one of the most innovative, groundbreaking technologies, Medtronic is redefining spine procedures to help reduce variability and improve outcomes with the ultimate goal of restoring long-term quality of life for more patients.

“Medtronic now becomes the first company to be able to offer an integrated solution, including artificial intelligence-driven surgical planning, personalised spinal implants, and robotic-assisted surgical delivery, which puts the power of these smart technologies directly into the hands of clinicians to make patient care more tailored and personalised.”

Over 30 products with 510(k) cleared or CE-Marked implant technologies used in spinal surgeries for adult deformity, paediatric deformity, and degenerative disease are part of Medicrea’s portfolio.

Powered by predictive modelling and sophisticated algorithms, the Medicrea solution measures and digitally reconstructs the spine to its optimal profile.

MEDICREA UNiDAdaptive Spine Intelligence (ASI) enables the surgeon to choose customised surgical plan selected from a database of over 6,000 surgical cases.

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network